Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development (Q38358028)

2 September 2017

title

Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development (English)

1 reference

2 September 2017

1 reference

hepatocellular carcinoma

1 reference

Caixia Chen

1

1 reference

2 September 2017

Changgong Zhang

2

1 reference

2 September 2017

Guohong Zhuang

3

1 reference

2 September 2017

Hongfang Luo

4

1 reference

2 September 2017

Jinhua Su

5

1 reference

2 September 2017

Pinh Yin

6

1 reference

2 September 2017

Juan Wang

7

1 reference

2 September 2017

publication date

1 December 2008

1 reference

2 September 2017

1 reference

2 September 2017

volume

26

1 reference

2 September 2017

issue

10

1 reference

2 September 2017

page(s)

965-974

1 reference

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Modulation of macrophage differentiation and activation by decoy receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Attenuation of Th1 response in decoy receptor 3 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Fas ligand‐induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900801975256

10.1080/07357900801975256

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference